Australia markets closed

Soleno Therapeutics, Inc. (SLNO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
37.89+0.55 (+1.47%)
At close: 04:00PM EDT
35.80 -2.09 (-5.52%)
After hours: 06:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.27B
Enterprise value 1.10B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)8.04
Enterprise value/revenue N/A
Enterprise value/EBITDA -29.87

Trading information

Stock price history

Beta (5Y monthly) -1.54
52-week change 3938.08%
S&P500 52-week change 322.36%
52-week high 353.82
52-week low 33.38
50-day moving average 343.17
200-day moving average 328.43

Share statistics

Avg vol (3-month) 3309.34k
Avg vol (10-day) 3279.44k
Shares outstanding 533.41M
Implied shares outstanding 633.41M
Float 813.71M
% held by insiders 12.01%
% held by institutions 194.89%
Shares short (15 Apr 2024) 43.1M
Short ratio (15 Apr 2024) 49.42
Short % of float (15 Apr 2024) 416.76%
Short % of shares outstanding (15 Apr 2024) 49.29%
Shares short (prior month 15 Mar 2024) 42.3M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Oct 2017
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 326 Aug 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-23.33%
Return on equity (ttm)-46.45%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -36.71M
Net income avi to common (ttm)-38.99M
Diluted EPS (ttm)-2.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)169.68M
Total cash per share (mrq)5.23
Total debt (mrq)403k
Total debt/equity (mrq)0.26%
Current ratio (mrq)14.89
Book value per share (mrq)4.97

Cash flow statement

Operating cash flow (ttm)-24.94M
Levered free cash flow (ttm)-12.82M